Seer (SEER) Capital Expenditures (2020 - 2026)
Seer (SEER) posted quarterly Capital Expenditures of $9000.0 for Q1 2026, down 98.62% year-over-year from $654000.0 in Q1 2025, and down 96.92% quarter-over-quarter from $292000.0 in Q4 2025.
Seer (SEER) Capital Expenditures (2020 - 2026) Analysis & Trends
Seer's Capital Expenditures history runs 7 years deep, the most recent figure standing at $9000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 98.62% year-over-year to $9000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 69.46% YoY), while the FY2025 annual figure was $1.8 million, down 49.86% from the prior year.
- Capital Expenditures for Q1 2026 stood at $9000.0, down from $292000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $7.1 million in Q4 2023, with the low at -$1.0 million in Q3 2023.
- The 5-year median for Capital Expenditures is $466000.0 (2024), against an average of $767823.5.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures slumped 135.53% in 2022, then jumped 1589.24% in 2023.
- Seer's Capital Expenditures stood at -$474000.0 in 2022, then surged by 1589.24% to $7.1 million in 2023, then slumped by 107.59% to -$536000.0 in 2024, then jumped by 154.48% to $292000.0 in 2025, then sank by 96.92% to $9000.0 in 2026.
- Business Quant data shows SEER's Capital Expenditures at $9000.0 in Q1 2026, $292000.0 in Q4 2025, and $283000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9,000.00 |
| Jun 30, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 283,000.00 |
| Sep 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Dec 31, 2024 | -536,000.00 |
| Dec 31, 2024 | -536,000.00 |
| Sep 30, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 466,000.00 |
| Mar 31, 2024 | 466,000.00 |